In utero stem cell transplantation: two steps forward but one step back?

Bibliography

• BILLINGHAM R, BRENT EL, MEDAWAR PB: 'Activelyacquired tolerance' of foreign cells. Nature (Lond.). (1953) 172:603–606.
   PubMed Web of Science ®Google Scholar
• OWEN RD: Immunogenetic consequences of vascularanastomoses between bovine twins. Science (1945) 102:400–401.
   PubMed Web of Science ®Google Scholar
• VAN DIJK BA, BOOMSMA DI. DE MAN AJM: Blood-group chimerism in human multiple births is not rare. Am.J. Med. Genet. (1996) 61:264–268.
   PubMed Web of Science ®Google Scholar
• Reinforces the original 'experiments of nature' by showing that in utero tolerance is not uncommon. WEST L, MORRIS JPJ, WOOD KJ: Fetal liver haemato-poietic cells and tolerance to organ allografts. Lancet (1994) 343:148–149.
   Google Scholar
• ANDERSON EM, JONES DRE, LIU DTY, EVANS AA:Gestational age and cell viability determine the effect of frozen storage on human fetal hematopoietic progenitor cell preparations. Fetal. Diagn. Ther. (1996) 11:427–432.
   PubMed Web of Science ®Google Scholar
• JONES DRE: Why do in utero stem cell transplantssometimes fail? Mol Med. Today. (1999) 5:288–291.
   Google Scholar
• JONES DRE, ANDERSON EM, EVANS AA, LIU DTY: Long-term storage of human fetal hematopoietic progenitor cells and their subsequent reconstitution - implications formn utero transplantation. Bone Marrow Transplant. (1995) 16:297–301.
   PubMed Web of Science ®Google Scholar
• LINDTON B, MARKLING L, RINGDÉN 0, KJAELDGAARD A, GUSTAFSON 0, WESTGREN M: Mixed lymphocyte culture of human fetal liver cells. Fetal Diagn. Ther. (2000) 15:71–78.
   PubMed Web of Science ®Google Scholar
• RENDA MC, FECAROTTA E, DIELI F et al.: Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant. (2000) 25:135–141.
   PubMed Web of Science ®Google Scholar
• • Investigations which suggest immune function in the fetal liver.
   Google Scholar
• BYRNE JA, STANKOVIC AK, COOPER MD: A novel subpopulation of primed T cells in the human fetus. J. Immunol. (1994) 152:3098–3106.
   PubMed Web of Science ®Google Scholar
• • An alternative view of the significance of immune cells in the fetus.
   Google Scholar
• KIM HB, SHAABAN AF, MILNER R, FIGHTER C, FLAKE AW: In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J. Pediatr. Surg. (1999) 34:726–730.
   PubMed Web of Science ®Google Scholar
• •• A thorough study of the mechanisms by which tolerance canbe achieved in utero.
   Google Scholar
• FLAKE AW, ZANJANI ED: Role of the alloimmune response after in utero hematopoietic stem cell transplantation. Blood (2000)96:1608–1609.
   PubMed Web of Science ®Google Scholar
• JONES DRE, ANDERSON EM, LIU DTY, WALKER RM: Tolerance induction following in utero stem cell transplantation. In: Stem Cells from Cord Blood, in utero Stem cell Development and Transplantation-Inclusive Gene Therapy, Workshop 33. Holzgreve W, Lessl M (Eds.), Springer-Verlag, Berlin Heidelberg (2000):187–196.
   Google Scholar
• ZANJANI ED, ALMEIDA-PORADA G, FLAKE AW: The human/sheep xenograft model: A large animal model of human hematopoiesis. Int. J. Hematol. (1996) 63:179–192.
   PubMed Web of Science ®Google Scholar
• JONES DRE, LIU DTY, ANDERSON EM, LAMMING GE Transplantation of human fetal liver-derived haematopoietic stem cells into sheep in utero. In Correction of Genetic Disorders by Transplantation, vol. IV. Ringdén 0, Hobbs JR, Steward CG (Eds.): COGENT Trust, London (1997):130–136.
   Google Scholar
• ANDREANI M, MANNA M, LUCARELLI G et al.: Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood (1996) 87:3494–3499.
   PubMed Web of Science ®Google Scholar
• • Evidence from adult thalassaemia patients which has relevance to IUT for this condition.
   Google Scholar
• ANDREANI M, NESCI S, LUCARELLI G et al.: Long-term survival of ex-thalassemic patients with persistent mixed chirnerism after bone marrow transplantation. Bone Marrow Transplant. (2000) 25:401–404.
   PubMed Web of Science ®Google Scholar
• WESTGREN M, SHIELDS LE: In utero stem cell transplan-tation in humans. In: Stem Cells from Cord Blood, in utero Stem cell Development and Transplantation-Inclusive Gene Therapy, Workshop 33. Holzgreve W, Lessl M (Eds.), Springer-Verlag, Berlin Heidelberg (2000):197–221.
   Google Scholar
• WESTGREN M, RINGDEN 0, EIK-NES S et al.: Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobino-pathies. Transplantation (1996) 61:1176–1179.
   Google Scholar
• HAYWARD A, AMBRUSO D, BATTAGLIA F et al.: Microchirnerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn. Ther. (1998) 13:8–14.
   PubMed Web of Science ®Google Scholar
• •• A good workup of the consequences of an IUT which hasapparently failed.
   Google Scholar
• FLEISCHMAN RA, CUSTER RP MINTZ B: Totipotent hematopoietic stem cells: normal self-renewal and differentiation after transplantation between mouse fetuses. Cell (1982) 30:351–359.
   PubMed Web of Science ®Google Scholar
• CARRIER E, LEE TH, BUSCH MP, COWAN MJ: Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem-cells. Blood (1995) 86:4681–4690
   PubMed Web of Science ®Google Scholar
• • An important paper because the transplant recipients did not have a haematological defect.
   Google Scholar
• KIM HB, SHAABAN AF, YANG EY, LIECHTY KW, FLAKE AW: Microchimerism and tolerance after in utero bone marrow transplantation in mice. J. Surg. Res. (1998) 77:1–5.
   PubMed Web of Science ®Google Scholar
• MINTZ B, ANTHONY K, LITWIN S Monoclonal derivation of mouse myeloid and lymphoid lineages from totipotent hematopoietic stem cells experimentally engrafted in fetal hosts. Proc. Natl. Acad. Sci. USA (1984) 81:7835–7839.
   PubMed Web of Science ®Google Scholar
• UCHIDA N, FLEMING WH, ALPERN EJ, WEISSMAN IL: Heterogeneity of hematopoietic stem cells. Curr. Opin. Immunol. (1993) 5:177–184.
   PubMed Web of Science ®Google Scholar
• WEEK( SF, VAN BOCKSTAELE DR, PLUM J et al.: CD34+ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood and adult bone marrow respond differently to hematopoietic cytolcines depending on the ontogenic source. Exp. Hematol. (1998) 26:1034–1042.
   PubMed Web of Science ®Google Scholar
• •• A seminal paper outlining the differences between stemcells from various sources.
   Google Scholar
• HARRISON DE, ZHONG RK, JORDAN CT, LEMISCHKA IR, ASTLE CM: Relative to adult marrow, fetal liver repopu-lates nearly five times more effectively long-term than short-term. Exp. Hematol. (1997) 25:293–297.
   PubMed Web of Science ®Google Scholar
• • A useful reference to the functional differences between stem cells.
   Google Scholar
• LANSDORP PM: Telomere length and proliferation potential of hematopoietic stem cells. J. Cell Sci. (1995) 108:1–6.
   PubMed Web of Science ®Google Scholar
• ZANJANI ED, ASCENSAO JL, TAVASSOLI M: Liver-derivedfetal hematopoietic stem cells selectively and prefer-entially home to the fetal bone marrow. Blood (1993) 81:399–404.
   PubMed Web of Science ®Google Scholar
• PITTENGER MF, MACKAY AM, BECK SC et al.: Muhilineage potential of adult human mesenchymal stem cells. Science (1999) 284:143–147.
   PubMed Web of Science ®Google Scholar
• LIECHTY KW, MACKENZIE TC, SHAABAN AF et al.: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Med. (2000) 6:1282–1286.
   PubMed Web of Science ®Google Scholar
• •• A milestone in our understanding of stem cell function andpotential.
   Google Scholar
• PARTRIDGE ARTRIDGET: The 'fantastic voyage' of muscle progenitor cells. Nature Med. (1998) 4:554–555.
   PubMed Web of Science ®Google Scholar
• ZANJANI ED, ANDERSON WF: Prospects for in utero human gene therapy. Science (1999) 285:2084–2088.
   PubMed Web of Science ®Google Scholar
• • A good overview of the state of gene therapy at the beginning of the new millennium.
   Google Scholar
• CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT-BASILE G et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288:669–672.
   Google Scholar
• •• A seminal paper with the first convincing series of genetherapy cases. Future developments from this group are eagerly awaited.
   Google Scholar
• SENUT MC, GAGE FH: Prenatal gene therapy: can the technical hurdles be overcome? Mol. Med. Today (1999) 5:152–156.
   Google Scholar
• • A good overview.
   Google Scholar
• CLAPP DW, DUMENCO LL, HATZOGLOU M, GERSON SL: Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer. Blood (1991) 78:1132–1139.
   PubMed Web of Science ®Google Scholar
• LANFRANCHI A, NEVA A, TETTONI K et al.: In utero transplantations (IUT) of parental CD34+ cells in three patients affected by primary irnmunodeficiencies. Bone Marrow Transplant. (1998) 21:127.
   PubMed Web of Science ®Google Scholar